MicroRNA expression in tumor cells from Waldenstrom's macroglobulinemia reflects both their normal and malignant cell counterparts

Blood Cancer Journal

Volumn 1, Issue 6, 2011, Pages

  Hodge, L S ^a   Elsawa, S F ^a   Grote, D M ^a   Price Troska, T L ^a   Asmann, Y W ^a   Fonseca, R ^b   Gertz, M A ^a   Witzig, T E ^a   Novak, A J ^a   Ansell, S M ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

B lymphocyte; MicroRNA; Plasma cell; Waldenstrom's macroglobulinemia

Indexed keywords

CD19 ANTIGEN; MICRORNA; MICRORNA 125B; MICRORNA 152; MICRORNA 181A; MICRORNA 182; MICRORNA 193B; MICRORNA 21; MICRORNA 223; MICRORNA 363; MICRORNA 9; SYNDECAN 1; TRANSCRIPTOME; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL LINEAGE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; TUMOR CELL; WALDENSTROEM MACROGLOBULINEMIA;

EID: 84864054931     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2011.25     Document Type: Article

References (60)

1. Owen RG, Treon SP, Al-Katib A, Fonseca R, Greipp PR, McMaster ML et al. Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's macroglobulinemia. Semin Oncol 2003; 30: 110-115. (Pubitemid 36506291)
2. Remstein ED, Hanson CA, Kyle RA, Hodnefield JM, Kurtin PJ. Despite apparent morphologic and immunophenotypic heterogeneity, Waldenstrom's macroglobulinemia is consistently composed of cells along a morphologic continuum of small lymphocytes, plasmacytoid lymphocytes, and plasma cells. Semin Oncol 2003; 30: 182-186. (Pubitemid 36506306)
3. Dohner H, Stilgenbauer S, Bener A, Leupolt E, Krober A, Bullinger L et al. Genomic aberrations and survival in chronic lymphocytic leukemia. NEJM 2000; 343: 1910-1916. (Pubitemid 32064784)
4. Liebisch P, Dohner H. Cyogenetics and molecular cytogenetics in multiple myeloma. Eur J Cancer 2006; 42: 1520-1529. (Pubitemid 44118770)
5. Schop RFJ, Jalal SM, Van Wier SA, Ahmann GJ, Bailey RJ, Kyle RA et al. Deletions of 17p13.1 and 13q14 are uncommon in Waldenstrom macroglobulinemia clonal cells and mostly seen at the time of disease progression. Cancer Genet Cytogenet 2002; 132: 55-60. (Pubitemid 34136052)
6. Chng WJ, Schop RF, Price-Troska T, Ghobrial I, Kay N, Jelinek DF et al. Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma. Blood 2006; 108: 2755-2763.
7. Gutierrez NC, Ocio EM, de las Rivas J, Maiso P, Delgado M, Ferminan E et al. Gene expression profiling of B lymphocytes and plasma cells from Waldenstrom's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma, and normal individuals. Leukemia 2007; 21: 541-549.
8. Hatjiharissi E, Ngo H, Leontovich AA, Leleu X, Timm M, Melhem M et al. Proteomic analysis of Waldenstrom macroglobulinemia. Cancer Res 2007; 67: 3777-3784. (Pubitemid 46762164)
9. Iorio MV, Croce CM. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009; 27: 5848-5856.
10. Meister G, Tuschl T. Mechanisms of gene silencing by doublestranded RNA. Nature 2004; 431: 343-349. (Pubitemid 39265674)
11. Cheng AM, Byrom MW, Shelton J, Ford LP. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucl Acids Res 2005; 33: 1290-1297. (Pubitemid 41439922)
12. Pasquinelli AE, Ruvkun G. Control of developmental timing by micrornas and their targets. Annu Rev Cell Dev Bio 2002; 18: 495-513. (Pubitemid 35387359)
13. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
14. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83-86. (Pubitemid 38055775)
15. Lawrie CH, Saunder NJ, Soneji S, Palazzo S, Dunlop HM, Cooper CDO et al. MicroRNA expression in lymphocyte development and malignancy. Leukemia 2008; 22: 1440-1446. (Pubitemid 352006091)
16. Esquela-Kerscher A, Slack FJ. OncomiRs: microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
17. Calin GA, Sevignani C, Dumitru CD, Hyslop T, noch E, Yendamuri S et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. PNAS 2004; 101: 2999-3004. (Pubitemid 38327724)
18. Malumbres R, Sarosiek KA, Cubedo E, Ruiz JW, Jiang X, Gascoyne RD et al. Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas. Blood 2009; 113: 3754-3764.
19. Roccaro AM, Sacco A, Chen C, Runnels J, Leleu X, Azab F et al. MicroRNA expression in the biology, prognosis, and therapy of Waldenstrom macroglobulinemia. Blood 2009; 30: 4391-4402.
20. Huber W, von Heydebreck A, Sueltmann H, Poustka A, Vingron M. Parameter estimation for the calibration and variance stabilization of microarry data. Stat Appl Genet Mol Biol 2003; 2: 3.
21. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG. The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res 2008; 37: D155-D158.
22. Betel D, Wilson M, Gabow A, Marks DS, Sander C. The mircoRNA.org resource: targets and expression. Nucleic Acids Res 2008; 36: D149-D153.
23. John B, Enright AJ, Aravin A, Tuschi T, Sander C, DS M. Human microRNA targets. PLoS Biol 2005; 3: e264.
24. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838. (Pubitemid 40839735)
25. Wang M, Tan LP, Dijkstra MK, van Lom K, Robertus JL, Harms G et al. miRNA analysis in B-cell chronic lymphocytic leukaemia: proliferation centres characterized by low miR-159 and high BIC/mIR-155 expression. J Pathol 2008; 215: 13-20. (Pubitemid 351619871)
26. Stone MJ, Pascual V. Pathophysiology of Waldenstrom's macroglobulinemia. Haematologica 2010; 95: 359-364.
27. Gururajan M, Haga CL, Das S, Leu CM, Hodson D, Josson S et al. MicroRNA 125b inhibition of B cell differentiation in germinal centers. Int Immunol 2010; 22: 583-592.
28. Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010; 467: 86-91.
29. O'Connell RM, Chaudhuri AA, Rao DS, Gibson WSJ, Balazs AB, Baltimore D. MicroRNAs enriched in hematopoietic stem cells differentially regulate long-term hematoipoietic output. PNAS 2010; 107: 14235-14240.
30. Hunter Z, Cao Y, Lewicki M, Sun J, Tseng H, Hanzis C et al. Aberrant expression of regulatory miRNAs and transcripts for IRS-PI3K growth and survival signaling in Waldenstrom's macroglobulinemia. American Society of Hematology. Orlando, FL, 2010.
31. Roccaro AM, Sacco A, Thompson B, Leleu X, Azab AK, Azab F et al. MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. Blood 2009; 113: 6669-6680.
32. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. PNAS 2004; 101: 11755-11760. (Pubitemid 39095368)
33. Merkerova M, Belickova M, Bruchova H. Differential expression of microRNAs in hematopoietic cell lineages. Eur J Haematol 2008; 81: 304-310.
34. Navarro A, Gaya A, Martinez A, Urbano-Ispizua A, Pons A, Balague O et al. MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 2008; 111: 2825-2832.
35. Stumpel DJPM, Schotte D, Lange-Turenhout EAM, Schneider P, Seslija L, de Menezes RX et al. Hypermethylation of specific microRNA genes in MLL-rearranged infant acute lymphoblastic leukemia: major matters at a micro scale. Leukemia 2010; 25: 429-439.
36. Ballabio E, Mitchell T, van Kester MS, Taylor S, HM D, Chi J et al. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential. Blood 2010; 116: 1105-1113.
37. Darnell JE, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in respnose to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415-1421. (Pubitemid 24217131)
38. Lwin T, Lin J, Choi YS, Zhang X, Moscinski LC, Wright KL et al. Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a. Blood 2010; 116: 5228-5236.
39. Angelin-Duclos C, Cattoretti G, Lin KI, Calame K. Commitment of B lymphocytes to a plasma cell fate is associated with blimp-1 expression in vivo. J Immunol 2000; 165: 5462-5471.
40. Klein U, Casola S, Cattoretti G, Shen Q, Lia M, Mo T et al. Transcription factor IRF4 controls plasma cell differentiation and class-switch recombination. Nat Immunol 2006; 7: 773-782. (Pubitemid 43905877)
41. Fukuda T, Yoshida T, Okada S, Hatano M, Miki T, Ishibashi K et al. Disruption of the Bcl6 gene results in an impaired germinal center formation. JEM 1997; 186: 439-448. (Pubitemid 27332902)
42. Nie K, Gomez M, Landgraf P, Garcia JF, Liu Y, Tan LHC et al. MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol 2008; 173: 242-252. (Pubitemid 351947971)
43. Stahlhut Espinosa CE, Slack FJ. The role of microRNAs in cancer. Yale J Biol Med 2006; 79: 131-140.
44. Kern W, Haferlach T, Schnittiger S, Haferlach C. Cytogenetic aberrations in lymphoplasmacytic lymphoma (LPL): a study of 166 cases. American Society for Hematology. Orlando, FL 2010.
45. Braggio E, Keats JJ, Leleu X, Van Wier S, Jimenez-Zepeda VH, Valdez R et al. Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kB signaling pathways in Waldenstrom's macroglobulinemia. Cancer Res 2009; 69: 3579-3588.
46. Loffler D, Brocke-Heidrich K, Pfeifer G, Stocsits C, Hackermuller J, Kretzschmar AK et al. Interleukin-6-dependent survival of multiple myeloma cells involves the Stat3-mediated induction of micro-RNA-21 through a highly conserved enhancer. Blood 2007; 110: 1330-1333. (Pubitemid 47281433)
47. Meng F, Henson R, Wehbe-Janek H, Smith H, Ueno Y, Patel T. The microRNA let-7a modulates interleukin-6-dependent Stat3 survival signaling in malignant human cholangiocytes. J Biol Chem 2007; 282: 8256-8264. (Pubitemid 47093612)
48. van der Fits L, van Kester MS, Qin Y, Out-Luiting JJ, Smit F, Zoutman WH et al. MicroRNA-21 expression in CD4+ T cells is regulated by Stat3 and is pathologically involved in Sezary Syndrome. J Invest Dermatol 2011; 131: 762-768.
49. Hatzmichael EC, Christou L, Bai M, Kolios G, Kefala L, Bourantas KL. Serum levels of IL-6 and its soluble receptor (sIL-6R) in Waldenstrom's macroglobulinemia. Eur J Haematol 2001; 66: 1-6. (Pubitemid 32099402)
50. Onnis A, De Falco G, Antonicelli G, Onorati M, Bellan C, Sherman O et al. Alteration of microRNAs regulated by c-Myc in Burkitt lymphoma. PLoS One 2010; 5: 12960.
51. Zhang J, Jima DD, Jacobs C, Fischer R, Gottwein E, Huang G et al. Patterns of microRNA expression characterize stages of human B-cell differentiation. Blood 2009; 113: 4586-4594.
52. Gibcus JH, Tan LP, Harms G, Schakel RN, de Jong D, Blokzijl T et al. Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia 2009; 11: 167-176.
53. Yamanaka Y, Tagawa H, Takahashi N, Watanabe A, Guo YM, Iwamoto K et al. Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer cell lymphoma/leukemia. Blood 2009; 114: 3265-3275.
54. Pons A, Nomdedeu B, Navarro A, Gaya A, Gel B, Diaz T et al. Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leuk Lymphoma 2009; 50: 1854-1859.
55. Li QJ, Chau J, Ebert PJ, Sylvester G, MIn H, Liu G et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 2007; 129: 147-161. (Pubitemid 46507589)
56. Di Lisio L, Gomez-Lopez G, BSanchez-Beato M, Gomez-Abad C, Rodriguez ME, Villuendas R et al. Mantle cell lymphoma: transcriptional regulation by microRNAs. Leukemia 2010; 24: 1335-1342.
57. Stittrich AB, Haftmann C, Hegazy A, Floessdorf M, Dong J, Fuhrmann F et al. MicroRNA-182 promotes clonal expansion of activated T helper cells. Ann Rheum Dis 2010; 69: A65.
58. Unno K, Zhou Y, Zimmerman T, Platanias LC, Wickrema A. Identification of a novel microRNA cluster miR-193b-365 in multiple myeloma. Leuk Lymphoma 2009; 50: 1865-1871.
59. Stamatopoulos B, Meuleman N, Haibe-Kains B, Saussoy P, Van Den Neste E, Michaux L et al. microRNA-29c and imcroRNA0223 downregulation has in vivo significance in chronic lymphocytic leukemia and improve disease risk stratification. Blood 2009; 113: 5237-5245.
60. Li C, Kim SW, Rai D, Bolla AR, Adhvaryu S, Kinney MC et al. Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma. Blood 2009; 113: 6681-6690.